Fostamatinib disodium: Completed Phase III enrollment

Rigel completed enrollment of 75 patients with platelet counts consistently <30,000/uL of blood in a double-blind, placebo-controlled Phase III trial evaluating 100 mg oral fostamatinib twice daily fo...